abstract |
Compound of formula I (wherein wedge-like bond, R 1 , R 2 , R 3 , R 4 , R 5 , R 5a , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , X and Y have the meanings given in the specification) and pharmaceutically acceptable salts thereof, which are affected by cancer and angiogenesis inhibition Compounds useful for treatment are provided. |